Tiziana Life Sciences Ltd.: FDA Grants Permission to Enroll

This Intermediate-Size Patient Population Expanded Access program will follow the same clinical dosing regimen as the two ongoing single-patient expanded access programs in SPMS patients.Tiziana

Related Keywords

Boston , Massachusetts , United States , Irina Koffler , Hana Malik , Howard Weiner , Tanuja Chitnis , Tiziana Life Sciences , Tiziana Press , Lifesci Advisors , Tiziana Life Sciences Ltd , Drug Administration , Sclerosis Program , Study May Proceed Letter , Institutional Review Board , Multiple Sclerosis Program , Scientific Advisory Board , Neuropsychiatric Dis , Press Release , Life Sciences , Sci Advisors , Tiziana , Life , Ciences , Migrants , Permission , Unenroll , Dditional , Secondary , Progressive , Multiple , Clerosis , Pms , Patients , Xpanded , Access , Program , Intranasal , Foralumab ,